The elusive link: EBV in MS

Area of Science:

• Neuroimmunology
• Virology
• Epidemiology

Background:

• The established link between Epstein-Barr Virus (EBV) infection and Multiple Sclerosis (MS) risk necessitates further investigation into the underlying pathogenic mechanisms.
• The complex interplay of EBV subtypes, host immunity, and environmental factors contributes to the unclear relationship between EBV and MS development.

Purpose of the Study:

• To review the molecular mechanisms by which EBV may contribute to MS pathogenesis across relapsing-remitting and progressive disease.
• To explore how MS risk factors and disease-modifying therapies (DMTs) interact with EBV and influence MS pathophysiology.

Main Methods:

• Literature search of PubMed and Medline databases.
• Keywords included 'Epstein-Barr Virus,' 'Multiple Sclerosis,' 'disease-modifying therapies,' and 'EBV activity.'
• Synthesis of evidence to address EBV's role in MS pathophysiology and treatment efficacy.

Main Results:

• EBV's molecular contribution to MS pathogenesis is explored across different MS types.
• The influence of MS risk factors and the efficacy of DMTs are examined in the context of EBV activity.
• The review addresses how EBV may explain the effects of certain risk factors and treatment outcomes.

Conclusions:

• Targeting EBV infection and replication is crucial for discovering an MS cure.
• Suppression of EBV protein expression and targeting viral reservoirs are key strategies to prevent MS disease activity, progression, and neurodegeneration.
• Addressing EBV is vital for managing MS, considering genetic factors and immune-mediated damage.